Global Neuromodulation Devices Markets, 2021-2027 with 2023 as the Base Year - Future Growth Potential Enhanced by Expanding Clinical Indications and Technological Advancements
13 oct. 2023 06h13 HE | Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Neuromodulation Devices Market, Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.This research service analyzes the...
Global Neuromodulation Strategic Research Report 2023: Market to Reach $11.6 Billion by 2030 - Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
29 sept. 2023 04h13 HE | Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Neuromodulation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Neuromodulation Market to Reach...
Final Logo-01.png
Neuromodulation Market is estimated to be US$ 12.23 billion by 2030 with a CAGR of 8.9% during the forecast period – By PMI
28 sept. 2023 13h00 HE | PMI
Covina, Sept. 28, 2023 (GLOBE NEWSWIRE) -- What is Neuromodulation? Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of...
Synapse Dental Completes Equity Financing Round with Backing From AAO Innovation & Transformation Fund
22 sept. 2023 08h00 HE | Synapse Dental
CRANSTON, R.I., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Synapse Dental, the maker of the Dental Pain EraserTM, announced the completion of its first outside equity financing with backing from the...
URIS Neuromodulation System
STIMVIA Unveils Innovative Solution to Transform CNS Disorder Treatments at TechCrunch Disrupt 2023
20 sept. 2023 12h00 HE | STIMVIA s.r.o.
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- STIMVIA, a pioneer medical technology company, introduces an effective non-invasive neuromodulation treatment, URIS®, addressing deep brain...
Logo transparent PNG.png
PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device
14 sept. 2023 06h00 HE | PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Brain Implants Market to hit USD 10 billion by 2032, says Global Market Insights Inc.
10 sept. 2023 19h30 HE | Global Market Insights Inc.
Selbyville, Delaware, Sept. 10, 2023 (GLOBE NEWSWIRE) -- Brain Implants Market size is expected to be worth USD 10 billion by 2032. The growing burden of neurological disorders along with the...
electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC
13 juil. 2023 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that ReletexTM by Reliefband,...
Synapse Dental Pain Eraser Receives 2023 Cellerant Best of Class Hygiene Award for Setting a New Standard of Patient Care in Dentistry
12 juil. 2023 09h00 HE | Synapse Dental
CRANSTON, R.I., July 12, 2023 (GLOBE NEWSWIRE) -- The Synapse Dental Pain Eraser – the world’s first pen-shaped, portable, electronic dental anesthesia solution to prevent and relieve oral pain...
Magstim LOGO.JPG
Advanced FDA Cleared Magstim Horizon 3.0 Transcranial Magnetic Stimulation Now Available in United Kingdom
07 juil. 2023 07h09 HE | Magstim EGI
WHITLAND, United Kingdom, July 07, 2023 (GLOBE NEWSWIRE) -- The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for...